Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

December 22, 2020January 5, 2021

FDA Expands Labels for 3 Vertex CFTR Modulators

cystic fibrosis, News

The U.S. Food and Drug Administration (FDA) has expanded the number of cystic fibrosis (CF)-related mutations considered responsive to and therefore eligible for Vertex Pharmaceuticals‘ three approved therapies. With these ... Read more

December 15, 2020December 15, 2020

CF Foundation Awards Research Projects to Advance Therapies for All CF Patients

cystic fibrosis, News

The Cystic Fibrosis Foundation has awarded a total of $1.7 million in nine grants to research projects focused on tools and strategies to advance therapies for all cystic fibrosis ... Read more

December 8, 2020December 8, 2020

Beyond Air Launches Pivotal Trial of LungFit Go Inhaled NO for NTM Lung Infections

News

Beyond Air has launched a pilot clinical trial evaluating its investigational therapy LungFit GO — inhaled nitric oxide that can be self-administrated at home — in adults with or ... Read more

November 26, 2020November 26, 2020

Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe

News, syndicated

The first wave of COVID-19 in Europe severely disrupted access to care and raised stress and anxiety in people with rare diseases, negatively affecting their health and well-being, according to ... Read more

October 29, 2020November 2, 2020

Screening for Carriers of CF May Be Cost-free Option for Couples in Australia

cystic fibrosis, News

The Australian Medical Services Advisory Committee (MSAC) has recommended that the costs of screening for mutations known to cause cystic fibrosis (CF), spinal muscular atrophy (SMA), and fragile X syndrome ... Read more

October 13, 2020October 13, 2020

Trial of Oral CB-280 for Chronic Lung Infections in CF Enrolling Across US

cystic fibrosis, News

A Phase 1b clinical trial evaluating Calithera Biosciences’ investigational oral therapy CB-280 is recruiting adults with cystic fibrosis (CF) and chronic airway infections at several U.S. sites. The trial’s ... Read more

October 2, 2020October 2, 2020

NTM Infection Rate in Young CF Patients in UK Remains Stable But High, Study Finds

cystic fibrosis, News

The frequency of nontuberculous mycobacteria (NTM) infections in children and adolescents with cystic fibrosis (CF) in the U.K. remained stable from 2016 to 2018, but substantially higher than at ... Read more

September 25, 2020September 25, 2020

Emily’s Entourage Awards $790K to Support Work on CF Therapeutics

cystic fibrosis, News

Nonprofit Emily’s Entourage has awarded a total of $790,000 to four research projects focused on potential therapies for cystic fibrosis (CF) and related lung infections. To be given over ... Read more

September 4, 2020September 4, 2020

CF Patients With Poorer Lung Function at Greater Risk of Premature or Smaller Baby, Study Shows

cystic fibrosis, News

Pregnancy is generally safe for both women with cystic fibrosis (CF) and their child, but those with poorer lung function are at greater risk of having a premature or smaller baby, ... Read more

July 30, 2020July 30, 2020

Thread-based Wearable Device May Help Diagnose, Monitor CF and Other Conditions

cystic fibrosis, News

Researchers have developed the first thread-based flexible patch that can be sewn into clothing to monitor — in real time — several molecules in sweat, including chloride ions, which ... Read more